2019
DOI: 10.1007/s00415-018-09172-1
|View full text |Cite
|
Sign up to set email alerts
|

Clinical effect of successful reperfusion in patients presenting with NIHSS < 8: data from the BEYOND-SWIFT registry

Abstract: Background and purpose If patients presenting with large vessel occlusions (LVO) and mild symptoms should be treated with endvoascular treatment (EVT) remains unclear. Aims of this study were (1) assessing the safety and technical efficacy of EVT in patients with NIHSS < 8 as opposed to a comparison group of patients presenting with NIHSS ≥ 8 and (2) evaluation of the clinical effect of reperfusion in patients with NIHSS < 8. Methods Patients included into the retrospec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 50 publications
1
8
0
Order By: Relevance
“…A previous survey on neurointerventionalists showed increasing aggressiveness in selecting patients for MT after publication of the 2015 trials 18. Since that time, studies have demonstrated that MT is safe with a high rate of good outcomes in patients presenting with National Institute of Health Stroke Scale score of <8 19–22. A meta-analysis of seven randomized controlled MT trials showed significantly better functional outcomes with MT compared with medical management for patients presenting with more severe infarct burden as measured by pre-procedure ASPECTS scores as low as 3–6 23.…”
Section: Discussionmentioning
confidence: 99%
“…A previous survey on neurointerventionalists showed increasing aggressiveness in selecting patients for MT after publication of the 2015 trials 18. Since that time, studies have demonstrated that MT is safe with a high rate of good outcomes in patients presenting with National Institute of Health Stroke Scale score of <8 19–22. A meta-analysis of seven randomized controlled MT trials showed significantly better functional outcomes with MT compared with medical management for patients presenting with more severe infarct burden as measured by pre-procedure ASPECTS scores as low as 3–6 23.…”
Section: Discussionmentioning
confidence: 99%
“…Details of the BEYOND-SWIFT Registry are in the public domain (NCT03496064) and have been published previously 24. Briefly, the registry is a retrospective, multicenter, non-randomized observational study designed to investigate the safety and efficacy of a Medtronic market-released neurothrombectomy device (applied as the initial device used for interventions) in patients with acute ischemic stroke who do not fulfill treatment eligibility requirements according to the current guidelines.…”
Section: Methodsmentioning
confidence: 99%
“…Details on the registry (BEYOND-SWIFT [Registry for Evaluating Outcome of Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy]) are registered at NCT03496064 and further details were published previously. 9 Patient consent was obtained according to Good Clinical Practice or institutional review board or local or institutional policies.…”
Section: Methodsmentioning
confidence: 99%